Nature Cancer is a journal dedicated to publishing the latest advances across all areas of cancer research.
New York, USA
Based in United Kingdom
- Tweets 2,040
- Following 371
- Followers 40,152
- Likes 1,973
🎃The October issue is live!
✅Computational cytopathology
✅PEGASUS trial
✅Stroke fuels glioma progression
✅Adipocyte methionine in cancer cachexia
✅and more
nature.com/natcancer/volumes…
2
2
831
📢Our September Issue is out!
Read about generative AI for digital pathology, cancer immunometabolism, GITR antibody optimization, l-glutamine combination therapy, and more
🔗nature.com/natcancer/volumes…
2
6
15
2,283
Our August issue is live!🏖️
Featuring copper dependency in AML, iron-mediated ferroptosis, GPNMB-directed CAR-T cell therapy, IDH1-mutant vaccine in phase 1 trial, and more
🔗nature.com/natcancer/volumes…
2
5
19
2,306
☀️Check out our July issue !
✅Tertiary lymphoid structures
✅DNA vaccine for GBM
✅CAR T cell therapy in lung metastases
✅adjuvant chemotherapy in nasopharyngeal carcinoma
✅neutrophil-driven contact-dependent immune suppression
✅GABA in GBM
nature.com/natcancer/volumes…
1
6
15
2,434
🌟Online today
A micropeptide encoded by the lncRNA USP30-AS1 promotes tumor growth by attenuating cGAS–STING–type I IFN signaling in macrophages
nature.com/articles/s43018-0…
3
11
25
3,350
🌻Check out our June issue !
✅Metastatic dissemination in CRC
✅Immunotherapy in GBM
✅BH3 mimetics sensitization in AML
✅ctDNA and PSA to monitor prostate cancer
✅Methylation-based CNS tumor classification
and more
nature.com/natcancer/volumes…
5
25
3,225
🍓☀️Check out our May Issue, now live!
Including:
☑️Oncolytic virus and cytokine-based gene therapies
☑️Myeloid plasticity, part of our Series on Tumor Heterogeneity and Plasticity
☑️DeepFAN, a model for human-AI collaboration
and more!
nature.com/natcancer/volumes…
4
7
1,508
🌟Online now!
The Review on myeloid cell plasticity in cancer therapy by Dmitry Gabrilovich & colleagues @GabrilovichLab
🔗nature.com/articles/s43018-0…
Check out the rest of the Series on Tumor Heterogeneity and Plasticity here:
nature.com/collections/gfbbj…
11
37
3,379
⭐️Check out the Perspective on cellular neighborhoods in cancer by @LichunMa, @KaiTanLab1 & co
🔗nature.com/articles/s43018-0…
Part of our Series on Tumor Heterogeneity and Plasticity:
nature.com/collections/gfbbj…
2
17
65
4,502
🌷Our April Issue is out!
Featuring:
☑️Our Series on Tumor Heterogeneity and Plasticity
☑️CAR T cell therapy in solid tumors
☑️An erythrocyte–anti-PD1 conjugate
☑️Pediatric tumors classification using cfDNA methylation
and more!
nature.com/natcancer/volumes…
1
7
32
2,593
📢Today we launch our Series on Tumor Heterogeneity and Plasticity featuring commissioned Reviews and a selection of articles published in Nature Cancer!
Read about EMT, CAF plasticity, immune cell plasticity, cellular neighborhoods and more here:
🔗nature.com/collections/gfbbj…
1
57
185
10,691
🌟New Perspective out today presents the recent advances in predicting TCR–epitope recognition and the therapeutic applications in cancer immunotherapy.
by @GfellerD and colleagues
🔗nature.com/articles/s43018-0…
4
24
2,215
🌟New study in Nature Cancer evaluates the clinical significance of early PSMA upregulation in patients with metastatic castrate-resistant prostate cancer treated with enzalutamide with or without 177Lu-PSMA-617.
by @drlouiseemmett & colleagues
nature.com/articles/s43018-0…
2
4
8
1,321
🚨Our March issue is now live! Have a look at Nature Cancer issue featuring
✅HER2+ breast cancer
✅TNBC & immunotherapy
✅Proteomic imaging
✅m6A epitranscriptomics
✅AI in breast screening
✅GENEVA platform models
...and more...
nature.com/natcancer/volumes…
1
8
3,436
🌟Out today at Nature Cancer
Stromal cells and chemokine gradients organize the loss of tissue architecture in lymph nodes in B cell lymphoma
by Judith B. Zaugg, Daniel Hübschmann, Simon Haas & Sascha Dietrich & co
nature.com/articles/s43018-0…
12
55
4,441
📢Come join our editorial team @NatureCancer
We're hiring an Associate or Senior Editor!
Apply to join our team in Shanghai, Beijing, Nanjing or Madrid.
⏲️Application deadline: March 29th
Details:
👉springernature.wd3.myworkday…
2
7
1,551
📢Hot off the press @NatureCancer
Don’t miss these 3 new Articles along with the accompanying News&Views on the use of AI in breast cancer screening!
3
6
11
2,075
🚨 Our February Issue is out!
Featuring:
☑️ Neoadjuvant PD‑1 in desmoplastic melanoma
☑️ FBXL2 inhibition sensitizes HER2‑neg breast cancer
☑️ Genomic model for prostate cancer screening
☑️ Organoid model for H3.3K27M glioma
…and more!
nature.com/natcancer/volumes…
1
2
20
4,789
🌟New Resource article
Read about the pancancer landscape of cancer-specific cell-free DNA methylation and fragmentomic features from plasma samples from 1,294 patients
✒️Yong Zeng, @MatLupien, @PughLab, Housheng Hansen He & colleagues
nature.com/articles/s43018-0…
1
18
58
4,352
PERSPECTIVE hot off the press @NatureCancer ! 'Setting higher standards for reports of microbial species in human cancers'
🔗nature.com/articles/s43018-0…
✒️By Steven Salzberg, Jacques Neefjes & Niranjan Nagarajan and co-authors
#tumormicrobiome
12
22
2,435
SpaceCat analyzes multiplex imaging data and establishes spatial patterns within triple-negative breast cancer microenvironment that are predictive of immune checkpoint blockade response across treatment time course.
nature.com/articles/s43018-0…
5
17
1,444
QUICHE is a computational method that analyzes proteomic imaging and detects differentially enriched cellular niches, including low-prevalence niches. The tool informs antitumor responses in triple-negative breast cancer.
nature.com/articles/s43018-0…
1
2
15
1,528
📢Don't miss this recently published @NatureCancer Article!
'METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers'
✒️By Housheng Hansen He, Xin Xu and colleagues
🔗nature.com/articles/s43018-0…
25
83
8,764
❄️Our January Issue is out!
Featuring:
☑️immune atlas in multiple myeloma
☑️tumor microbiome in head & neck cancer
☑️MEK–RAF molecular glue against RAS/BRAF-mutant cancers
☑️atypical EMT
☑️CheckMate 77T phase 3 trial in patients with NSCLC
and more!
nature.com/natcancer/volumes…
2
32
112
10,074
🌟New Perspective at Nature Cancer
Tan and colleagues discuss recent advances in spatial omics and computational models that inform the classification and clinical relevance of cellular neighborhoods in cancer.
🔗nature.com/articles/s43018-0…
@cdktmw
13
29
3,224
🌟New Perspective to read at Nature Cancer
Learn about the current clinical and preclinical evidence of the effects of GLP-1 medicines on cancer outcomes and their mechanism in cancer cells and the TME.
✏️Julian M. Yabut & @DanielJDrucker
nature.com/articles/s43018-0…
2
6
1,706
🚨Nature Cancer’s 2025 In Review Focus is here! Discover the year’s most impactful developments in cancer research and oncology, with insights from leading experts and curated highlights from top studies.
nature.com/collections/icejj…
1
1
16
5,825
🍂In case you haven't yet done so, check out our October issue now!
🔗nature.com/natcancer/volumes…
1
2
3,483
🍂Our September issue is OUT NOW!
Featuring, among others:
- A Perspective on #drugconjugates
- #immunotherapy studies
- research on GBM invasion
- method for #singlecell analyses of #CTCs
🔗nature.com/natcancer/volumes…
1
9
58
9,687
Our August issue is OUT NOW! ☀️
Check it out here:
🔗nature.com/natcancer/volumes…
⭐️Featuring:
- review on #nanotechnology for immuno-oncology
- review on #ferroptosis for #cancertherapy
- AI in clinical oncology
- cancer #cachexia
- #immunotherapy clinical trial
1
2
22
5,703
🚨Don't miss the July issue of Nature Cancer!
Check it out here:
🔗nature.com/natcancer/volumes…
Featuring:
⭐️Review on clonal hematopoiesis in cancer
⭐️Review on CAR engineering for cancer therapy
⭐️immunotherapy
⭐️AI for tumour classification
⭐️single-cell analyses in B-ALL
1
2
23
5,568
📢We’ve partnered with MD Anderson to explore recent breakthroughs in understanding the tumor ecosystem and how its various components influence cancer development, progression, diagnosis, and treatment. Learn more and save your seat!
🔗go.nature.com/44cJT9Z
11
44
7,988
🚨 New article alert! 🚨 Check out our last release by Eric M. Thompson and colleagues, testing a peptide vaccine in CAYA with recurrent high-grade glioma and medulloblastoma in their phase I trial 🧠
👉 nature.com/articles/s43018-0…
6
1,682
🔔We’ve partnered with MD Anderson to explore recent breakthroughs in understanding the tumor ecosystem and how its various components influence cancer development, progression, diagnosis, and treatment. Learn more and save your seat:
go.nature.com/44cJT9Z
6
14
2,461
Join us for discussions and panels on the latest research advancing our understanding of the tumor ecosystem and its influence over cancer development and treatment @NatureConf @NaturePortfolio
👉natureconferences.streamgo.l…
1
11
18
10,933
🛎️Register NOW for the webinar on Liquid Biopsies in Clinical Oncology hosted by @NatureCancer and @NatureBiotech!
🔗cassyni.com/events/5evgfsJt5…
⭐️Speakers:
Caroline Dive
Lillian Siu
⏰Wednesday 11th June 2025, 10am ET/3pm UK time
Chairs: Eleni Skourti & Barbara Chiefet
3
6
5,142
Inside April Issue: have a look at Nature Cancer issue featuring GEP-NETs, CART, prostate cancer, renal cell carcinoma, bacteria in cancer therapy, gallbladder lesions, lung cancer, ESMO TAT reports, and much more
👉nature.com/natcancer/
3
6
1,746
🎂Our 5-YEAR ANNIVERSARY Issue is now ONLINE!
@NatureCancer
Find it here:
📎nature.com/natcancer/volumes…
We celebrate this milestone, sharing with you a collection of:
⭐️Reviews and opinion pieces
⭐️Research articles
on key developments in #cancerresearch and #oncology
3
23
3,414
🚨Don't miss The #HTAN live webinar later today!
🔗 workcast.com/register?cpak=2…
With HTAN leaders: Li Ding, Ken Lau, Shannon Hughes and Michael Snyder
Chaired by: Alexia-Ileana Zaromytidou (Chief Editor, Nature Cancer)
Produced by: Nature/Nature Portfolio
2
2
1,591
Reach out to our editor Julieta Alfonso at @KeystoneSymp from next Saturday 18th January "Neural Influence on Cancer, Tumor Microenvironment and Cancer Immunology"
3
5
1,775
🚨Check out the @NatureCancer Editorial featuring in our #2024inReview Focus Issue!
'The highs and lows of 2024'
overviewing the Focus Issue exciting content!
🔗doi.org/10.1038/s43018-024-0…
1
3
1,228
⭐️Don't miss our 2024 year-in-review Focus Issue!
🔗nature.com/collections/chieg…
Featuring:
*Editorial on 2024 #cancerresearch highlights
*#newPIs Viewpoint
*#AI and #spatialomics in #oncology
*(CAR-)T cell therapies in cancer
*12 Research Highlights on remarkable 2024 publications
1
1
13
8,301
📢Our November issue is OUT NOW! @NatureCancer
📎nature.com/natcancer/volumes…
⭐️Featuring, among others:
#HTAN pieces on tumor evolution and chromatin accessibility
CAR-T research
#EMT
#LLPS in breast cancer
mutant #EGFR in lung cancer
1
10
4,534
Our Associate Editor Tiffanie Chouleur is attending the @AACR Special Conference on Liquid Biopsy next week in San Diego. Reach out if you want to discuss your science or publishing in @NatureCancer
2
1,995
New content 🌟Perspective🌟
"Targeting therapy-persistent residual disease"
by Xiaoxiao Sun, Lani Wu, Steven Altschuler & Aaron Hata @ucsfpharmacy @MGHCancerCenter
🔗nature.com/articles/s43018-0…
1
36
91
13,817
News & Views by Sigrid Ruuls & Paul Parren
"Antibody avidity meets multiple myeloma"
🔗nature.com/articles/s43018-0…
Mario Perro & colleagues develop a CD3+ T cell engager co-targeting BCMA and CD38 to improve immunotherapy for multiple myeloma, demonstrate cytotoxicity in patient-derived samples and murine models and develop a quantitative systems pharmacology model
🔗nature.com/articles/s43018-0…
8
44
7,111
ONLINE NOW - our September issue
👇
nature.com/natcancer/volumes…
ALT Multiomic profiling identifies a targetable role for Type III-associated immune responses in the development of immunotherapy-induced toxicities in melanoma.
1
7
35
13,576
🔔ONLINE NOW! the @NatureCancer August issue! 🤩 Features:
- #machinelearning models in #clinicaloncology
- EGFR and PI3K inhibition to overcome adaptive resistance
- effects of cancer cell nucleotide metabolism on immune #TME
👇
nature.com/natcancer/volumes…
9
18
5,434
ONLINE – the @NatureCancer June issue! 🤩
Read on:
- tumor vascularization
- clinical trials in breast cancer and in sarcoma
- precision oncology
- DNA replication stress in PDAC
- targeting AML with prolyl hydroxylase inhibitor
- cancer epigenomes
nature.com/natcancer/volumes…
1
18
6,101
Join us for the Meet-the-Editor panel at #EACR2024 RTM Stage at 9:00 AM to learn about publishing and ask your 🔥questions about @NatureCancer.
3
2
2,079
ONLINE NOW – the
@NatureCancer May issue!🌷
#metabolism, #immunotherapy, #metastasis and more!
👇
nature.com/natcancer/volumes…
Cover from Astuti et al on link of efferocytosis to macrophage reprogramming & liver metastasis in this issue.
(Image: Yuliana Astuti, Design: Allen Beattie)
1
15
35
11,784
Our @NatureCancer Senior Editor @LisaHaas0107 Lisa Hoffmann-Haas is attending the CIMT meeting in Mainz 🇩🇪. Reach out to her if you want to discuss your science and publishing in Nature Cancer or find her at the meet-the-editor table (Booth #33) at 3PM today.
#CIMT2024
2
9
2,544
ONLINE NOW – the @NatureCancer April issue! 🌺🌻🌷
Check out the content on #ferroptosis, #survivorship, #immunotherapy, #metabolism and more.
And isn’t the cover puzzling 🧩? Find it here: nature.com/natcancer/volumes…
1
14
2,127
WE ARE HIRING @NatureCancer
2 Locum Associate/Senior Editors - Berlin, Heidelberg, London – application deadline May 8th
A permanent Associate/Senior Editor - Shanghai, Beijing, New York or Philadelphia– application deadline April 28th
Please spread the word! Links 👇
1
5
17
9,057
✨ONLINE NOW @NatureCancer “Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies” #CARTcells
nature.com/articles/s43018-0…
1
6
2,700
✨ONLINE NOW @NatureCancer “Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies” #CARTcells
nature.com/articles/s43018-0…
8
33
5,344
💫DON’T MISS @NatureCancer “A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors”
nature.com/articles/s43018-0…
5
13
3,360
⭐️NEW CONTENT @NatureCancer “Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells”
nature.com/articles/s43018-0…
6
12
2,429
✨ONLINE NOW @NatureCancer “Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy” #immunotherapy
nature.com/articles/s43018-0…
7
11
2,590
⭐️NEW CONTENT @NatureCancer “Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols” #immunotherapy
nature.com/articles/s43018-0…
22
67
8,027
✨DON’T MISS @NatureCancer “Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study”
nature.com/articles/s43018-0…
1
1,312
💫ONLINE NOW @NatureCancer “Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity” #TumorImmunology
nature.com/articles/s43018-0…
7
12
2,695
⭐️NEW CONTENT @NatureCancer “Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial” #ClinicalTrial #BreastCancer
nature.com/articles/s43018-0…
3
1
1,664
NEW REVIEW ARTICLE @NatureCancer – “Aneuploidy and complex genomic rearrangements in cancer evolution” by @VanLooLab #TobyMBaker #SaraWaise #MaximeTarabichi.
Read it here👇
nature.com/articles/s43018-0…
rdcu.be/dxoLb
1
37
96
12,919
✨Our first @NatureCancer issue of 2024 is LIVE – check out the new content on #cancermetabolism in pancreatic cancer and glioblastoma, #metastatsis in prostate cancer and the #microbiome.
Find it here👇
nature.com/natcancer/volumes…
4
38
140
11,224
📢Come join our @NatureCancer editorial team!
We're hiring an Associate/Senior Editor in our NY, Berlin & Heidelberg offices🌎. Application deadline January 9th.
Find details here:
careers.springernature.com/j…
1
7
12
14,306
✨In our #2023InReview special we provide a collection of 12 research highlights summarizing impactful papers published in 2023 and present a collection of some of our most striking @NatureCancer publications.
Check them out for some end-of-year reading.
nature.com/collections/bcggj…
1
30
81
31,306
💫ONLINE NOW @NatureCancer – the #2023Generation – 12 group leaders share their journey to becoming an independent PI. Very inspiring stories, please do not miss them!
nature.com/articles/s43018-0…
1
31
108
26,917